Age 18 and older, with active RA.
Experienced inadequate clinical response or who have been unable to tolerate standard RA therapies.
To be eligible, potential participants must have tried and not responded to or been able to tolerate etanercept (Enbrel), infliximab (Remicade), or adalimumab (Humira) therapy for a particular length of time (specified during screening).
If you would like additional information on these trials, Please contact our Srudy Coordinator Dawn Bynum at 562-243-8199 or by email at dolanresearch@yahoo.com
You may also visit www.researchra.com to take an online survey to see if you may qualify for the above referenced trials.
Choosing to participate in a clinical trial is an important personal decision, to learn more about being a Clinical Trial Participant click here.